The launch of European Consortium EHVA (European HIV Vaccine Alliance) coordinated by Inserm and the VRI (Vaccine Research Institute).

January 26, 2016, Paris, France and Lausanne, Switzerland. The European Commission has granted over 22 million Euros to the European HIV Vaccine Alliance (EHVA) to develop a multidisciplinary platform to evaluate novel preventive and therapeutic vaccines. The grant is supplemented with additional 6 million Euros from the Swiss government for the Swiss project partners.

Link to the press release of Inserm